Oppenheimer & CO Inc Eli Lilly & CO Transaction History

Oppenheimer & CO Inc

$6.52 Billion
Q4 2024

A detailed history of Oppenheimer & CO Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Oppenheimer & CO Inc holds 72,683 shares of LLY stock, worth $66.5 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

72,683

Previous 77,967 6.78%

Holding current value

$66.5 Million

Previous $69.1 Million 18.77%

% of portfolio

0.86%

Previous 1.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$727.2 - $932.06 $3.84 Million - $4.93 Million	-5,284 Reduced 6.78%	72,683 $56.1 Million
Q3 2024 Nov 05, 2024	SELL	$772.14 - $960.02 $1.23 Million - $1.53 Million	-1,596 Reduced 2.01%	77,967 $69.1 Million
Q2 2024 Aug 07, 2024	BUY	$724.87 - $909.04 $3.15 Million - $3.95 Million	4,344 Added 5.78%	79,563 $72 Million
Q1 2024 May 06, 2024	BUY	$592.2 - $792.28 $1.5 Million - $2.01 Million	2,533 Added 3.48%	75,219 $58.5 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $1.42 Million - $1.67 Million	2,702 Added 3.86%	72,686 $42.4 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $1.48 Million - $2.04 Million	3,397 Added 5.1%	69,984 $37.6 Million
Q2 2023 Aug 02, 2023	SELL	$350.74 - $468.98 $289,360 - $386,908	-825 Reduced 1.22%	66,587 $31.2 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $1.55 Million - $1.82 Million	-5,002 Reduced 6.91%	67,412 $23.2 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $1.77 Million - $2.07 Million	5,520 Added 8.25%	72,414 $26.5 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $396,097 - $451,394	-1,336 Reduced 1.96%	66,894 $21.6 Million
Q2 2022 Aug 08, 2022	BUY	$278.73 - $327.27 $1.73 Million - $2.03 Million	6,194 Added 9.98%	68,230 $22.1 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $728,947 - $905,895	3,106 Added 5.27%	62,036 $17.8 Million
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $390,564 - $484,692	1,737 Added 3.04%	58,930 $16.3 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.06 Million - $1.3 Million	-4,785 Reduced 7.72%	57,193 $13.2 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $648,535 - $838,875	3,592 Added 6.15%	61,978 $14.2 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $3.94 Million - $5.11 Million	-24,000 Reduced 29.13%	58,386 $10.9 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $1.45 Million - $1.92 Million	11,150 Added 15.65%	82,386 $13.9 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $3.67 Million - $4.24 Million	25,076 Added 54.32%	71,236 $10.5 Million
Q2 2020 Aug 11, 2020	SELL	$136.42 - $164.18 $405,030 - $487,450	-2,969 Reduced 6.04%	46,160 $7.58 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $96,073 - $118,911	-807 Reduced 1.62%	49,129 $6.82 Million
Q4 2019 Feb 07, 2020	BUY	$106.92 - $132.43 $194,273 - $240,625	1,817 Added 3.78%	49,936 $6.56 Million
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $961 - $1,045	-9 Reduced 0.02%	48,119 $5.38 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $1.52 Million - $1.77 Million	-13,724 Reduced 22.19%	48,128 $5.33 Million
Q1 2019 Apr 24, 2019	BUY	$111.31 - $131.02 $133,572 - $157,224	1,200 Added 1.98%	61,852 $8.03 Million
Q4 2018 Jan 29, 2019	BUY	$105.9 - $118.64 $228,955 - $256,499	2,162 Added 3.7%	60,652 $7.02 Million
Q3 2018 Oct 26, 2018	BUY	$85.86 - $107.31 $132,052 - $165,042	1,538 Added 2.7%	58,490 $6.28 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $35,124 - $40,312	-464 Reduced 0.81%	56,952 $4.86 Million
Q1 2018 May 01, 2018	BUY	$74.21 - $87.6 $238,585 - $281,634	3,215 Added 5.93%	57,416 $4.44 Million
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $191,575 - $205,486	2,338 Added 4.51%	54,201 $4.58 Million
Q3 2017 Nov 09, 2017	BUY	$77.07 - $85.54 $4 Million - $4.44 Million	51,863	51,863 $4.44 Million

Others Institutions Holding LLY

# of Institutions

4,272

Shares Held

757M

Call Options Held

10.2M

Put Options Held

11.4M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $869B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account

Oppenheimer & CO Inc Eli Lilly & CO Transaction History